Genostic: Migrating pharmacogenomics

Using pharmacogenomics to improve clinical decision making is not a new concept. However, Genostic Pharma Ltd. believes that attempts to develop genomics-based diagnostic tools "have been too high tech and complex," according to co-founder and director Gareth Roberts, "and the practice of medicine is not like that."

Nevertheless, Genostic still plans to use pharmacogenomic data coming out of the human genome project to

Read the full 626 word article

How to gain access

Continue reading with a
two-week free trial.